-+ 0.00%
-+ 0.00%
-+ 0.00%

NANOVIRICIDES, INC: SUFFICIENT QUANTITY OF NV-387 ORAL GUMMIES DRUG PRODUCT FOR STARTING CLINICAL TRIAL AGAINST EBOLA IS ALREADY AVAILABLE IN DRC

Reuters·07/22/2026 12:32:21

Please log in to view news